Evidence map›Paper›PMID 32624628›Full record

ReviewActa histochemica et cytochemica2020

Vitamin D and the Host-Gut Microbiome: A Brief Overview.

Nuraly S Akimbekov, Ilya Digel, Dinara K Sherelkhan, Afzalunnessa B Lutfor, Mohammed S Razzaque

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in Acta histochemica et cytochemica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07199829 (A Double-Blind Randomized Controlled Trial Evaluating Response to Vitamin D3 and K2 Supplementation Through Inflammatory Markers and the Gut Microbiome in Healthcare Personnel), which is not on this map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07199829 narecruitingnot on this mapstarted 2025, after this paper: background citation

A Double-Blind Randomized Controlled Trial Evaluating Response to Vitamin D3 and K2 Supplementation Through Inflammatory Markers and the Gut Microbiome in Healthcare Personnel

TypeinterventionalSponsorMadigan Army Medical CenterRan2025 to 2026Enrolled96ConditionsHypovitaminosis D, HypovitaminosisArmsVitamin Arm 1, Vitamin Arm 2, Vitamin Arm 3, Placebo
3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Serum 25-hydroxyvitamin D levels andArchives of medical science : AMS · 2026
    Article
  17. Review
  18. Article
  19. Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Nuraly S AkimbekovDepartment of Biotechnology, al-Farabi Kazakh National University, Almaty, Kazakhstan.
Ilya DigelInstitute for Bioengineering FH Aachen University of Applied Sciences, Jülich, Germany.
Dinara K SherelkhanDepartment of Biotechnology, al-Farabi Kazakh National University, Almaty, Kazakhstan.
Afzalunnessa B LutforDepartment of Microbiology, Ad-Din Women's Medical College, Dhaka, Bangladesh.
Mohammed S RazzaqueDepartment of Pathology, Lake Erie College of Osteopathic Medicine, Erie, PA, USA.
Al-Farabi Kazakh National University · KZFH Aachen · DELake Erie College of Osteopathic Medicine · USWomen Medical College · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a growing body of evidence for the effects of vitamin D on intestinal host-microbiome interactions related to gut dysbiosis and bowel inflammation. This brief review highlights the potential links between vitamin D and gut health, emphasizing the role of vitamin D in microbiological and immunological mechanisms of inflammatory bowel diseases. A comprehensive literature search was carried out in PubMed and Google Scholar using combinations of keywords "vitamin D," "intestines," "gut microflora," "bowel inflammation". Only articles published in English and related to the study topic are included in the review. We discuss how vitamin D (a) modulates intestinal microbiome function, (b) controls antimicrobial peptide expression, and (c) has a protective effect on epithelial barriers in the gut mucosa. Vitamin D and its nuclear receptor (VDR) regulate intestinal barrier integrity, and control innate and adaptive immunity in the gut. Metabolites from the gut microbiota may also regulate expression of VDR, while vitamin D may influence the gut microbiota and exert anti-inflammatory and immune-modulating effects. The underlying mechanism of vitamin D in the pathogenesis of bowel diseases is not fully understood, but maintaining an optimal vitamin D status appears to be beneficial for gut health. Future studies will shed light on the molecular mechanisms through which vitamin D and VDR interactions affect intestinal mucosal immunity, pathogen invasion, symbiont colonization, and antimicrobial peptide expression.

Indexed as

bowel inflammationgut microfloraintestinevitamin D

Identifiers

PMID32624628
PMCPMC7322162
OpenAlexW3035332418

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.